Close Menu

UCSF

This Week in PLOS

In PLOS this week: 'reverse genome-wide association study' method; genetic links between Familial Mediterranean Fever and ankylosing spondylitis; and more.

A team led by researchers at the University of California, San Francisco generated optical genome maps for 154 individuals from more than two dozen populations.

Sangamo Therapeutics has announced preliminary results from its gene-editing trial, the Associated Press reports.

Cancer Research UK has awarded nearly £60 million in funding to three US investigator-led research initiatives focused on cancer progression and drug response.

This Week in Cell

In Cell this week: approach for mapping enhancers and their targets, comparative protein interaction analysis of dengue and Zika viruses, and more.

Second X Helping

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

This Week in PNAS

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

This Week in Cell

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

The US Department of Health and Human Services says it has not cancelled a fetal tissue contract with a University of California, San Francisco, lab, Science reports.

The funding is being provided to a number of early-career investigators and collaborative research groups using genomics and other technologies.

Pages

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

The New York Times Magazine examines gender discrimination at the Salk Institute.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.